Skip to main content
Log in

ASO Visual Abstract: Comprehensive Analysis of Somatic Mutations in Driver Genes of Resected Pancreatic Ductal Adenocarcinoma Shows KRAS G12D and Mutant TP53 Combination as an Independent Predictor of Clinical Outcome

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Acknowledgment

This work was supported by the Nikki Mitchell Foundation and the Ben and Rose Cole Charitable Pria Foundation, Benedict Kinny-Köster is supported by the German Research Foundation (KI 2437/2-1).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun Yu MD, PhD.

Ethics declarations

Disclosure

There are no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shoucair, S., Habib, J.R., Pu, N. et al. ASO Visual Abstract: Comprehensive Analysis of Somatic Mutations in Driver Genes of Resected Pancreatic Ductal Adenocarcinoma Shows KRAS G12D and Mutant TP53 Combination as an Independent Predictor of Clinical Outcome. Ann Surg Oncol 29, 2732–2733 (2022). https://doi.org/10.1245/s10434-021-11180-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-11180-x

Navigation